Reduced firing rates of pyramidal cells in the frontal cortex of APP/PS1 can be restored by acute treatment with levetiracetam
Jan L. Klee, Amanda J. Kiliaan, Arto Lipponen, Francesco P. Battaglia
Topics & Concepts
LevetiracetamPyramidal cellNeuroscienceLocal field potentialFrontal cortexGenetically modified mousePathophysiologyEpilepsyAmyloid betaCerebral cortexHippocampusBiologyMedicineTransgenePathologyEndocrinologyDiseaseBiochemistryGeneAlzheimer's disease research and treatmentsNeuroscience and Neuropharmacology ResearchMemory and Neural Mechanisms